12:00 AM
 | 
Nov 11, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Results

TPM/oxymorphone patch: Phase I data

An Australian Phase I trial showed that all 12 healthy volunteers who received the first application of Phosphagenics' 3-day TPM/oxymorphone patch achieved oxymorphone plasma concentrations above...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >